[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB1132233A - Medicinal compositions containing sequestering and chelating agents - Google Patents

Medicinal compositions containing sequestering and chelating agents

Info

Publication number
GB1132233A
GB1132233A GB2082665A GB2082665A GB1132233A GB 1132233 A GB1132233 A GB 1132233A GB 2082665 A GB2082665 A GB 2082665A GB 2082665 A GB2082665 A GB 2082665A GB 1132233 A GB1132233 A GB 1132233A
Authority
GB
United Kingdom
Prior art keywords
acid
sodium
group
chelating agent
functional group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2082665A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FLOYD R MENCIMER
Original Assignee
FLOYD R MENCIMER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FLOYD R MENCIMER filed Critical FLOYD R MENCIMER
Priority to GB2082665A priority Critical patent/GB1132233A/en
Publication of GB1132233A publication Critical patent/GB1132233A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

1,132,233. Pharmaceutical compositions. H. ASHMEAD and F. R. MENCIMER. 17 Aug., 1965, No. 20826/65. Heading A5B. [Also in Division C3] A pharmaceutical composition for the treatment of calcific gall stones, renal calculi, inter alia consists of (a) a phosphate selected from sodium tripolyphosphate (Forms I and II), sodium hexametapyrophosphate, sodium hexametaphosphate, tetrasodium pyrophosphate, tetrapotassium pyrophosphate, S.Q. phosphate i.e. Na 8 P 6 O 11 and sodium acid pyrophosphate together with (b) a chelating agent selected from (I) N,N-di-(2-hydroxyethyl) glycine and the sodium salt thereof, N-(2-hydroxyethyl) ethylene diamine triacetic acid and the trisodium salt thereof, 1,2-diaminocyclohexane tetraacetic acid, nitrilotriacetic acid, 2-hydroxymethyl-5-hydroxy-pyran, and N,N,N'N'- tetrakis (2-hydroxypropyl) ethylene diamine Or (II) ethylene diamine tetraacetic acid, the mono-, di-, tri-, tetrasodium and calcium salts thereof, diethylene triamine pentaacetic acid and pentasodium diethylene triamine pentaacetate and/or (c) an ion-exchange material selected from (III) a resin having a carboxylic acid functional group, sodium alumino-silicate gel, a polystyrene matrix having a nuclear sulphonic acid functional group, a styrene-divinyl benzene copolymer matrix with sulphonic acid functional groups, a hydrocarbon matrix having phosphonic acid groups, a styrene-divinyl benzene copolymer matrix with a quaternary ammonium functional group, and a styrenedivinyl benzene copolymer matrix with a polyalkylamine functional group or (IV) (when the chelating agent, if present, is a chelating agent of group (I)) poly-N-vinyl-5-methyl-2- oxazolidinone and co-polymers of N-vinyl-5- methyl-2-oxazolidinone. When the chelating agent is of group I and/or the ion-exchange material is of group III, the composition may also contain a colloidal carrier e.g. carboxymethylcellulose, sodium carboxymethylcellulose. The invention also includes a composition comprising a phosphate as defined in (a) above together with a chelating agent selected from group I above and/or an ion exchange material selected from group IV above and a colloidal carrier. The compositions may include water as a carrier.
GB2082665A 1965-10-22 1965-10-22 Medicinal compositions containing sequestering and chelating agents Expired GB1132233A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2082665A GB1132233A (en) 1965-10-22 1965-10-22 Medicinal compositions containing sequestering and chelating agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2082665A GB1132233A (en) 1965-10-22 1965-10-22 Medicinal compositions containing sequestering and chelating agents

Publications (1)

Publication Number Publication Date
GB1132233A true GB1132233A (en) 1968-10-30

Family

ID=10152361

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2082665A Expired GB1132233A (en) 1965-10-22 1965-10-22 Medicinal compositions containing sequestering and chelating agents

Country Status (1)

Country Link
GB (1) GB1132233A (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4774258A (en) * 1978-05-20 1988-09-27 Martin Rubin Treatment of urinary calculi
US4774257A (en) * 1978-05-20 1988-09-27 Martin Rubin Treatment of urinary calculi
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
WO2005060978A2 (en) * 2003-12-22 2005-07-07 Universitá Degli Studi Di Siena Polymetaphosphate based formulations for therapy of microcrystalline arthropathies
US7019085B2 (en) * 2004-08-30 2006-03-28 Albright Robert L Phosphate selective resin and related methods
US9579425B2 (en) 2012-12-28 2017-02-28 Cook Medical Technologies Llc Cation exchange ureteral stent
WO2018165132A1 (en) * 2017-03-06 2018-09-13 University Of Houston System Polyphosphates as inhibitors of calcium crystallization
CN115583710A (en) * 2022-07-19 2023-01-10 江苏驰佳环保科技有限公司 Chelating agent and preparation method thereof
EP4221859A4 (en) * 2020-09-30 2024-10-23 Uop Llc Process for removing ions from bodily fluids

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4774257A (en) * 1978-05-20 1988-09-27 Martin Rubin Treatment of urinary calculi
US4774258A (en) * 1978-05-20 1988-09-27 Martin Rubin Treatment of urinary calculi
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
WO2005060978A2 (en) * 2003-12-22 2005-07-07 Universitá Degli Studi Di Siena Polymetaphosphate based formulations for therapy of microcrystalline arthropathies
WO2005060978A3 (en) * 2003-12-22 2005-08-04 Univ Siena Polymetaphosphate based formulations for therapy of microcrystalline arthropathies
US7019085B2 (en) * 2004-08-30 2006-03-28 Albright Robert L Phosphate selective resin and related methods
US9579425B2 (en) 2012-12-28 2017-02-28 Cook Medical Technologies Llc Cation exchange ureteral stent
WO2018165132A1 (en) * 2017-03-06 2018-09-13 University Of Houston System Polyphosphates as inhibitors of calcium crystallization
EP4221859A4 (en) * 2020-09-30 2024-10-23 Uop Llc Process for removing ions from bodily fluids
CN115583710A (en) * 2022-07-19 2023-01-10 江苏驰佳环保科技有限公司 Chelating agent and preparation method thereof

Similar Documents

Publication Publication Date Title
GB1132233A (en) Medicinal compositions containing sequestering and chelating agents
DE3370650D1 (en) Liquid detergent composition
GB1185386A (en) Abrasive Scouring Cleanser Compositions.
ES2080116T3 (en) CRYSTALLINE MONOSODIC SALT CRYSTALLINE ACID 4-AMINO-1-HYDROXYBUTYLIDENE-1,1-BISPHOSPHONIC, PROCEDURE FOR PRODUCING AND COMPOSITIONS AND USE OF THE SAME.
DE3367503D1 (en) Concentrate of disinfecting agent
MX168293B (en) IMPROVEMENTS TO DETERGENT COMPOSITION FOR PARTICULATE WASHING
ES2100565T3 (en) LIQUID OR GEL DISHWASHING DETERGENT CONTAINING A POLYHYDROXYLATED FATTY ACID AMID AND ALKYL POLYETHOXYPOLICARBOXYLATE.
US3671448A (en) Methods of scale inhibition using substoichiometric amounts of amino alcohol and phosphonic acids
CA2020858A1 (en) Water treatment agent and water treatment method for boiler
US5474704A (en) Regeneration compositions for cationic exchange resins
US4077997A (en) Diphosphonoalkane carboxylic acids, process of preparation and methods of use
DK0828812T3 (en) Cleaning compositions containing a crystalline builder material in selected particle size ranges for improved performance
US3784469A (en) Process of preventing scale and deposit formation in aqueous systems
ES502018A0 (en) A PROCEDURE FOR PREPARING A GRANULAR DETERGENT COMPOSITION
US3617577A (en) Method of inhibiting scale formation
MY108534A (en) Process for purifying n-phosphonomethylgycine
GB1288369A (en)
BR8101035A (en) PROCESS FOR THE PRODUCTION OF TYPE A CRYSTALLINE ZEOLITE
US2834735A (en) Producing an alcohol-base antifreeze containing an alkaline earth metal borate as aninhibitor
US2095836A (en) Photographic developer
SE8400789D0 (en) COMPOSITION AND METHOD FOR INHIBITING SCALE
AU2288183A (en) Stannic n-phosphonomethylglycine salts
FR2301593A1 (en) An additive for detergents and their compsns. - contg. a vitreous phosphate of specified formula
ES8404403A1 (en) Sodium tripolyphosphate having a high hydration rate, and detergent composition containing it.
AU554225B2 (en) Detergent additives based on aluminosilicate ion exchange